St. Jude Medical (STJ) Announces ILUMIEN III Trial Met Primary Endpoint
Go back to St. Jude Medical (STJ) Announces ILUMIEN III Trial Met Primary EndpointSt Jude Medical (NYSE: STJ) | Delayed: 80.82 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $80.82 | 52 Week High | $84.00 | |||
Open | $53.29 | 52 Week Low | $48.83 | |||
Day High | $80.82 | P/E | 32.59 | |||
Day Low | $80.82 | EPS | $2.48 | |||
Volume | 458,525 |